Cannabinoid | High Risk

THC Oil 25mg/mL (Cannatrek T25)

What to know about THC Oil 25mg/mL — also sold as Cannatrek T25, ANTG Mariposa, Beacon Medical THC25: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

THC Oil 25mg/mL (brand names: Cannatrek T25, ANTG Mariposa, Beacon Medical THC25) is classified as High risk (7 risk points) by AllMeds. It is a S8 medication under the TGA in Australia. High THC, significant impairment and dependency risk

Key Takeaways

  • TGA Schedule: S8 in Australia
  • Risk level: High (7 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S8 Not PBS listed

Risk Profile

Risk Level High
Risk Points 7
CNS Depressant No
Respiratory Risk No

High THC, significant impairment and dependency risk

How THC Oil 25mg/mL is regulated

THC Oil 25mg/mL is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as S8 under the Therapeutic Goods Administration (TGA).

Clinical Evidence

  • Cannabis-based medicines for chronic neuropathic pain — Cochrane Review - Mücke M, et al. (Cochrane) (2018)

    Cochrane review finding low-quality evidence that cannabis-based medicines may provide some relief for chronic neuropathic pain. Significant adverse effects noted.

    Cochrane systematic review — gold standard for evidence synthesis

  • SIRA: Medicinal Cannabis — S8 Requirements and Driving Impairment - SIRA NSW (2023)

    SIRA notes THC products carry driving impairment risk. NSW drug-driving laws apply regardless of medical authorisation. Insurer approval required.

    NSW workers comp regulator

  • Medicinal cannabis prescriptions surge in Australia - ABC News (2024)

    Reporting on the rapid growth of medicinal cannabis prescriptions in Australia via SAS pathway. Notes concerns about evidence base.

    National broadcaster

  • TGA: Medicinal Cannabis Access — THC Products (S8) - TGA (2024)

    THC products are Schedule 8. Require SAS-B or Authorised Prescriber pathway. Strict prescribing and monitoring requirements.

    TGA regulatory framework

Check this medication against your full medication list

Run a full risk assessment including THC Oil 25mg/mL interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.